Most of those assumptions are untested.

And in ANZ MedTech — a market defined by specialist expertise, small professional communities and long relationship memories — untested assumptions at the briefing stage don’t just slow a search down. They make failure the most likely outcome before anyone has picked up the phone.

What a wrong brief actually looks like

It rarely looks like an obvious mistake. It looks like a reasonable set of assumptions made by a capable leader who simply hasn’t had visibility of the current market before committing to a position.

The compensation brief that’s 18 months behind the market

• A base salary set at what the last person in the role earned.

• A car allowance that hasn’t moved since 2022.

• A commission structure that made sense when the territory was established but no longer reflects what candidates at that level expect.

The search launches. The right candidates are identified and approached.

The hiring leader assumes the market is being difficult. In reality, the brief was never calibrated against what the market is actually paying.

The talent pool brief built on assumption

“There are plenty of ortho reps in Sydney.” Maybe.

• But how many have the specific subspecialty experience the role requires?

• How many are within the relevant tenure window — experienced enough to contribute immediately, not so entrenched that a move requires a significant package premium?

• How many have existing relationships with the key accounts that matter?

Without mapping the total addressable talent pool before the search begins, a hiring leader is committing resources to a search whose viability is unknown.

They may be searching a pool of twelve genuinely qualified candidates — or two.

The EVP brief built on internal perception

• What does your organisation look like to the people you most want to hire? Not what your leadership team thinks it looks like.

• What do your direct competitors’ top performers actually think — about your products, your leadership, your culture, your trajectory?

In a small market where senior professionals talk to each other, perception travels fast.

Share Inside MedTech Hiring

The three questions a brief should answer before search begins

1. Is our compensation architecture competitive for this role in this market right now?

Not last year. Not what the last hire accepted. What the relevant talent pool — at the specific seniority, tenure and specialty level required — expects today. That means real data from real candidates in the relevant segment, not benchmarks pulled from salary surveys that aggregate across industries.

2. How large is the pool of genuinely qualified candidates — and where do they sit?

• Total addressable talent.

• Competitor team structures.

• Movement patterns. Tenure profiles.

• Adjacent capability — candidates who don’t hold the exact title but bring transferable expertise that could work. This is market mapping before mandate, not post-hoc justification for why a search is taking longer than expected.

3. What does our organisation look like from the outside — and what friction will we face?

Candidate sentiment.

• Why top performers in this segment join organisations like yours — or don’t.

• What objections arise in search conversations.

• Whether your EVP is landing or whether there are perception gaps that need to be addressed before you go to market.

Getting this wrong doesn’t just slow the search — it damages employer brand in a community where word travels.

Subscribe now

What happens when these questions go unanswered

1. The search takes longer than budgeted.

2. Candidates disengage at offer stage.

3. The shortlist is thinner than expected.

4. The hire is made under time pressure rather than on merit. Or the search fails entirely and starts again — with the same untested brief.

In a MedTech territory role, six months of vacancy is a direct commercial loss.

The ROI of getting the brief right before you start is not a nice-to-have. It’s the difference between a search that works and one that doesn’t.

Intelligence before action

DukeMed’s pre-search reports exist for exactly this gap — structured market intelligence commissioned before a mandate launches, so the brief is built on evidence rather than assumption.

Talent Index — maps the total addressable talent pool in your MedTech category. Identifies competitor team structures, movement patterns, and real headcount dynamics.

Answers the question: who actually exists in this market, and where are they?

Talent Compensation — calibrates your compensation architecture against real market benchmarks. Validates salary, incentive design and offer competitiveness before you enter negotiation.

Answers the question: what will it actually take to hire at this level right now?

Talent Pulse — surfaces candidate sentiment and qualitative friction points before your mandate launches. Understands why top talent joins — or rejects — your organisation versus direct competitors.

Answers the question: what does our employer brand look like to the people we most want to hire?

The Pre-Hire Insight diagnostic is a short, self-serve scorecard that identifies where your visibility gaps are greatest — in talent accessibility, offer calibration, or market perception — and points you toward the right intelligence framework before you begin.

Start with a Pre-Hire Insight →

They’ve been told their CV looks good. They’ve been added to databases. They’ve been promised a call when something comes up.

And then — nothing. Or a role that doesn’t fit. Or a process that goes quiet after two rounds.

The frustration is real. But it’s often based on a misunderstanding of what actually happens in a structured search — and what it’s looking for when it comes looking for you.

This isn’t a list of soft skills. It’s an explanation of the process that runs before you ever hear about a role — and what it surfaces when it does.

First: understand which process you’re in

There are two distinct hiring processes operating in the ANZ MedTech market right now.

The first is reactive and volume-based.

• A role gets posted.

• Applications come in.

• A recruiter sorts through CVs and sends a shortlist.

• The hiring manager picks the best available option from whoever applied.

The second is structured and search-led.

1. A mandate is defined. The relevant talent landscape is mapped — who exists, where they sit, how they’re positioned, what would prompt movement.

2. Selected professionals are approached directly, assessed against the specific role requirements, and progressed only if capability, motivation and risk profile all align.

Most professionals have experienced the first process. Very few have experienced the second — and many don’t know what it looks like from the inside, or what it’s actually assessing.

If you’ve spent a career talking to contingency recruiters who send CVs and hope for the best, the second process will feel different.

That’s the point.

What a structured search is actually assessing

1. Whether you’re visible before you’re looking

A structured search starts with market mapping — identifying who exists in the relevant talent pool before any outreach begins.

That mapping draws on what’s publicly visible: professional profiles, industry networks, referral circles, and prior search conversations.

It’s not purely a Linkedin exercise, but what’s publicly visible about you shapes whether you’re in scope before anyone has spoken to you.

A pattern that comes up consistently in conversations with ANZ MedTech professionals: experienced, capable people who are genuinely hard to find. Not because they lack credentials — because what’s publicly visible doesn’t reflect what they actually do, or where they’re headed.

A headline that just says a job title when the person has been running a national business. An About section that’s blank. A profile that reflects where someone was three years ago, not where they are now or where they’re capable of going.

The search process surfaces this gap early. Before you’re contacted, before you’re assessed, a structured search has already formed a view of your positioning — based on what it can see. If that view is incomplete or inaccurate, it affects whether you’re in scope at all.

2. Whether your commercial impact is legible

The most common gap I see across conversations with experienced MedTech professionals — including those at senior leadership level — is the inability to articulate commercial impact clearly and specifically.

Not responsibilities.

Revenue growth, territory built from scratch, market share shifted, tender won, team restructured and performing.

The specifics that tell a hiring leader what you actually delivered — not what your job description said you were supposed to do.

This gap is particularly pronounced in professionals coming off long tenures at large organisations. Strong performers who’ve been internally recognised but have never had to translate their commercial contribution into external language. The work was real. The results were significant. But they weren’t described in a way that travels beyond the organisation that already knows the context.

3. Whether your motivation is genuine and specific

A structured search isn’t just verifying capability. It’s assessing motivation — specifically, whether the reasons for considering a move are real, durable and aligned with the role on offer.

In conversations over the past year, the consistent driver isn’t dissatisfaction. It’s structural — a role that no longer fits the person’s scope, an organisation moving in a direction the individual doesn’t believe in, a reporting line that was meant to be temporary and became permanent. The move is considered, not reactive.

In some conversations, the clearest signal is the absence of clarity — a professional who knows they want to move but hasn’t yet worked out toward what. That ambiguity shows up in a search process as risk, not potential.

The instinct makes sense: they want someone who understands the market to help them think it through. But clarity about direction is a coaching problem, not a search problem.

A recruiter who needs to fill a role can’t be objective about whether you should move at all, or toward what. Those are different conversations — and it’s worth knowing which one you actually need.

Candidates who can answer the motivation question clearly progress faster and with less friction. Those who can’t often stall mid-process, not because the fit wasn’t there, but because the articulation wasn’t convincing.

4. Whether your risk profile fits the mandate

This is the part of structured assessment that most candidates don’t see coming — and that most CV-based processes never reach.

Risk profile assessment covers:

• restraint of trade obligations

• notice period realities

• geographic constraints

• compensation expectations relative to market

• and any background factors that could complicate a transition.

In conversations with senior professionals, these factors regularly surface as complexity that contingency recruiters either miss or ignore.

• A candidate with a non-compete covering their entire sector.

• A base salary expectation that reflects years of internal merit increases at a single organisation rather than current market rates.

• A relocation requirement attached to a current role that makes a clean exit complicated.

None of these are disqualifying on their own.

But in a structured search, they’re surfaced and understood early — not discovered at offer stage when they become deal-breakers.

A note for hiring leaders reading this

Some of the people reading this article are also the people commissioning searches — or who have in the past asked someone to put a name forward or share a CV.

That’s a different process to what’s described above.

It works when the fit is obvious and the timing is right. It doesn’t work reliably for senior or niche roles where the best candidate isn’t in anyone’s immediate network and isn’t actively signalling availability.

The distinction matters: a structured search isn’t a recruiter making calls and sending profiles. It’s a process with defined stages, assessment criteria and accountability. The CV is a reference document, not the product.

If you’ve been relying on informal referrals and contingency relationships to fill critical commercial roles in ANZ MedTech, you’ve likely experienced the gap that creates — either in search failure, late-stage dropout, or hires that looked right on paper and weren’t right in the role.

What to do with this

If you’re a MedTech professional reading this — employed, not publicly looking, but paying attention — the useful question(s) are:

If a structured search mapped your corner of the market this week, would you show up clearly?

Would your commercial impact be legible?

Would your motivation be articulable?

The Market Position Scorecard gives you a structured, private answer to that question. It benchmarks your positioning across the dimensions a search process actually assesses.

Benchmark your market position →

Or if you’d prefer to simply ask a question 🙋🏻‍♂️ or start a conversation before committing to anything:

One of the more useful things about running a structured diagnostic over time is that patterns emerge that aren’t visible in individual conversations.

"The Market Position scorecard intro page, for context:”

What the data shows

Across the scorecard to date1,536 professionals visited the landing page. Of those, 79 started the diagnostic and 56 completed it in full.

That gives a 15% visit-to-start rate and a 71% completion rate once someone begins.

Across completed responses, the average overall positioning score sits at 60% ✔️.

That’s not a failing grade. It’s a visibility gap.

The more useful signal is the score tier breakdown:

• 27% — Developing Positioning

• 65% — Calibrating Market Value

• 8% — Market Aligned

That middle tier tells the real story.

Most respondents are not starting from scratch. They have credible experience, market exposure and professional substance. But their external positioning has not fully caught up with their capability.

The highest-scoring areas were the more internal or role-based dimensions:

• Market Specification: 69%

• Core Competency Mapping: 66%

• Search Strategy & Execution: 65%

• Market-Calibrated Assets: 64%

• Commercial Alignment: 59%

These are signals of interest. MedTech professionals generally understand their market well, can identify where they fit, and have a grasp of their own capability and can articulate that.

The lower-scoring areas were more external:

• Network Equity: 37%

• Brand Authority: 41%

• Strategic Growth Value: 47%

This is where the gap lives.

Most professionals know what they’re good at.

Far fewer have built the external signals that make them findable before a role is advertised, before a search mandate goes live, or before a shortlist has already started to take shape.

A few other patterns worth noting

Around two-thirds of respondents have no mentor or industry advisor actively guiding their career decisions. Not informally, not formally. Just navigating solo.

Nearly nine in ten have not published anything or contributed to professional conversations online in any meaningful way.

More than half have never sought feedback from a recruiter on how their profile or CV actually reads to someone assessing them against a live mandate.

And yet — the majority say they are ready for a leadership role right now.

There’s nothing contradictory about that.

Readiness and visibility are different things.

What this means in practice

In a retained search, the first stage isn’t reviewing applicants. It’s mapping the market — identifying who actually exists, who’s performing well in comparable roles, and who might be open to a conversation.

That process finds people through signals: their professional footprint, their network connections, who they’ve worked with, what they’ve contributed to.

The professionals who get approached for roles they didn’t apply for aren’t necessarily the best in the market. They’re the ones who made themselves findable before the question was even asked.

Where to start

If you haven’t yet completed the scorecard, it takes about 5 minutes and gives you a structured view across eight dimensions — not a generic career quiz, but a self-positioning diagnostic2 built around how retained search actually works.

No call required. No follow-up unless you want one.

👉 Market Position Scorecard - Benchmark my Market Position

Your result is yours to use. Review the lowest-scoring category, decide what needs attention, and apply the insight to your LinkedIn profile, CV, network strategy or next career conversation.

If there is a specific question you want to sense-check, you can message Richard. Availability for individual conversations is limited due to active search work, so this scorecard is designed to give you useful direction without needing a call.

If you want a deeper read on how the invisible market operates — and why most senior MedTech roles never reach a job board — the full briefing is here on Inside MedTech Hiring 👇.

— Richard

These conversations often take place when professionals are reassessing their next move, sometimes following restructures, leadership changes, or shifts within their organisation.

While this is not a statistical sample, clear patterns are beginning to emerge.

Below are five signals shaping career movement in MedTech right now.

---

1. Restructures Are Driving Unexpected Career Moves

A recurring trigger for career movement is organisational restructuring rather than voluntary resignation or dissatisfaction.

Several professionals described roles disappearing or changing significantly due to cost rationalisation, portfolio shifts, or leadership changes. In many cases the individual had not been actively planning a move prior to the restructure.

These transitions often happen quickly and leave candidates navigating the market earlier than expected.

---

2. Employers Are Scrutinising Stability More Closely

Tenure continues to matter in MedTech hiring.

Candidates with several recent moves are aware that hiring managers may view short stints cautiously, particularly in senior commercial roles. As a result, professionals are increasingly conscious of how career transitions appear on a CV and how they explain those moves during interviews.

The perception of stability remains an important factor in leadership hiring decisions.

---

3. The Market Still Runs on Networks

Even when professionals have access to formal outplacement support or recruiters, the most common strategy for navigating a career move remains personal networks.

Industry relationships, former colleagues, and informal introductions continue to play a significant role in uncovering opportunities.

For many senior professionals, the visible job market represents only a small portion of potential roles.

---

4. Alignment Is Becoming More Important Than Titles

Several professionals described using a career transition to reassess the type of work they want to do.

Rather than simply moving to the next available leadership role, candidates are increasingly interested in positions that align with their background or interests. In MedTech this often means reconnecting with the clinical, scientific, or technical side of the industry.

Fit and long-term alignment are becoming more important considerations than title alone.

---

5. Explaining Career Movement Is Part of the Strategy

Professionals are increasingly aware that employers expect a clear narrative around career changes.

Candidates who have recently been promoted, changed companies, or experienced a restructure are thinking carefully about how those transitions will be interpreted by hiring managers.

Being able to articulate the context behind a move has become an important part of navigating the market.

---

If you’re seeing similar patterns across the sector, I’d be interested to hear your perspective.

Leave a comment

About These Signals

These insights are drawn from confidential conversations with senior MedTech professionals between September 2025 and March 2026.

They are not statistical findings but directional signals from experienced individuals navigating leadership careers in the sector.

Future editions will continue tracking how these patterns evolve across the MedTech sector.

Richard Duke is the founder of DukeMed, a specialist executive search firm focused on the MedTech sector.

---

Most MedTech organisations only start searching after the resignation letter lands. By then the cost is already running — lost revenue, disrupted accounts, and a search process launched under pressure rather than on strategy.

In a market defined by specialist expertise and relationship-led sales, reactive hiring isn’t just inefficient. It’s a revenue risk.

The five patterns below are the most common failure points I see in MedTech hiring.

1. The Hidden Cost ( of Reactive Hiring )

Most organisations engage a recruiter once a vacancy exists. In MedTech, where specialist capability takes months to develop and territory relationships are hard-won, that timing is already too late.

The talent that would make the most difference — high-performing professionals currently hitting their targets at a competitor — will never see your job ad. They’re not looking. They don’t need to be. They’re invisible to any process that starts with a job board.

The Shift: The shift required isn't just faster hiring. It's earlier visibility.

Understanding who exists in the relevant talent pool before a need becomes urgent is what separates a structured search from a reactive scramble.

2. The Internal-Only Trap: Why Familiarity Stifles Innovation

When a senior role opens, many leaders default to internal promotion. The instinct is understandable — loyalty, cultural fit, reduced onboarding friction.

The risk is less visible: organisations that hire exclusively from within develop a narrowing view of what good looks like. External mid-career leaders bring different commercial playbooks, competitor intelligence, and market relationships.

In a period defined by reimbursement reform, margin pressure and procurement complexity, that external perspective often carries more value than the familiarity of a known internal candidate.

The Reality: The strongest hiring decisions tend to combine internal pipeline awareness with an honest view of what the external market holds.

That requires actually mapping the external market — not assuming it.

3. What talent actually wants in 2026

The candidate value proposition has shifted.

Mid to senior MedTech professionals in 2026 are not making decisions based on perks, culture statements or flexible working policies alone. They are assessing commercial viability, technical pipeline, leadership quality, and — where available — equity or meaningful bonus structure.

The Employee Value Proposition for a senior MedTech role needs to function as a business case, not a lifestyle pitch. If you can’t articulate why this role represents a genuine commercial opportunity for the right person — including what the territory looks like, what the growth trajectory is, and what the realistic earnings ceiling is — the strongest candidates will decline to progress.

The Strategy: Offer calibration before you go to market matters. A role positioned incorrectly loses candidates at the point of interest, not at the point of offer.

Subscribe now

4. Replacing gut feel with structured assessment

“Seems like a good fit” is not an assessment framework.

In high-stakes MedTech hiring — senior commercial roles, leadership appointments, territory rebuilds — the cost of a wrong hire typically exceeds the annual salary of the position. Behavioural assessment for competencies specific to the role context — stakeholder mapping, commercial acumen, clinical credibility, resilience under financial pressure — is not optional at this level.

The Verdict: The QIA framework — Qualified, Interested, Assessed — is the standard applied in structured MedTech search. It replaces volume shortlisting with a disciplined process: candidates are only progressed when capability, motivation and risk profile have all been verified.

5. The Search-Led Insurance Policy-Treating search as a strategic asset

The MedTech leaders who consistently hire well don’t treat talent acquisition as a reactive function.

They treat it like an insurance policy — investing in market visibility before a need becomes urgent, so that when a transition occurs, the decision isn’t made under pressure.

That means knowing who exists in the relevant talent pool.

• Understanding how competitors are structured. Having a clear view of candidate sentiment and what would prompt movement.

• And being positioned to act quickly when the right person becomes available — rather than starting from zero when a vacancy opens.

In this market, the professionals who represent the strongest fit for senior ANZ MedTech roles are often already known — through prior relationships, referral networks, and direct conversation.

Search intelligence isn't a luxury for large organisations. In a niche market, it's the difference between filling a role well and filling it under duress.

The Bottom Line: If your current recruitment process relies on chance, you are leaving your market share to chance. In a high-stakes industry, “Good Enough” hiring is a strategy for stagnation.

Is your hiring process built for 2022 or 2026?

Before committing to a search, it's worth understanding exactly where your visibility gaps are — in talent accessibility, offer calibration, and market perception.

RUN THE PRE-HIRE DIAGNOSTIC 🔬

The Pre-Hire Insight diagnostic identifies those gaps in a focused conversation, with no commitment required.

In any competitive Medtech niche,the Counteroffer is inevitable.

But for both the Employee and the Employer, “in my experience over the years, it is almost always a mistake for both parties"

The scenario is standard: A high-performing Territory Manager resigns.

The Sales Director, fearing a vacant territory and lost revenue, immediately matches the offer + 10%.

The candidate accepts. Crisis averted?

No. You haven’t saved the employee; you have just rented them for another quarter.

The money has changed, but the root causes—lack of autonomy, blocked progression, or culture—remain.

Buying Time, Not Loyalty

Why do companies counter?

It is rarely about “love.”

It is about Operational Risk Management 🛡️.

1. Project Continuity: They need the employee to finish the Q1 launch.

2. Optics: Having to explain a resignation to the Global VP.

3. Cost: It is cheaper to pay someone $10k more now than to pay a $30k search fee tomorrow.

The Risk: If you make a counter-offer and word gets around ( it often does! ), you are signalling that the only way to get a raise in your business is to hold a gun to your head. This sets a dangerous precedent for the rest of the team.

The Outcome: Many managers who counter immediately start looking for a replacement behind the scenes. They are buying 3 months of stability while they find someone “loyal.”

The “Loyalty Tax” ( & The PIP Risk )

If you accept a counteroffer, you haven’t won.

You have painted a target on your back 🎯.

1. The Broken Trust

You are now the person who “tried to leave.

• When the next promotion comes up, will they give it to the flight risk?

• Or will they give it to the person who stayed?

2. The PIP Trap (Performance Improvement Plan)

A pattern I've observed more than once:a professional accepts a counteroffer, spends the next few weeks transitioning key account knowledge to the team — and is then quietly managed out later.

The organisation used the counteroffer to extract valuable knowledge before making the move they'd already decided on.

3. The “Band-Aid” Fix

The raise buys your compliance, not your happiness.

The frustration that led you to take a headhunt call or apply to well placed ad was one of: the micromanagement, the lack of new products, the territory size too big, too small etc —will return in <90 days.

​Conclusion:

The best career moves are decisive, and the best hires are planned with insight, context not knee-jerk reactions.

Hiring Managers:

Build a pipeline of “Warm Bench” talent or map the best in your field so you never have to panic-counter.

Candidates:

Leave Clean 🌱. If you resign, mean it. Leave on good terms, but leave.

This foundational guide was originally developed in 2022 and has been calibrated for the 2026 MedTech landscape.

Introduction: From “Volume” to “Value”

In 2022, the challenge was volume—finding anyone to fill a seat. Remember those times?

In 2026, the challenge is precision—finding the right commercial profile that can deliver immediate ROI in a tighter economic climate.

The “Post-and-Pray” method (posting ads and hoping for the best) no longer works for leadership or critical commercial roles. The top 15% of the market has gone underground.

They are not reading job ads, they are tired of the noise and despite recruiters or HR living on Linkedin - top talent doesn’t spend their time showing up here daily

Here are the 5 strategic shifts MedTech leaders must make to secure top talent this year.

1. Shift from “Inbound” to “Outbound”

The Old Way: “We need a Territory Manager. Let’s post an ad on LinkedIn.”

The 2026 Reality: High-performing sales professionals are not looking for jobs. They are busy hitting their targets.

The Strategy: You must treat recruitment like lead generation. Identify the “Ghost Market” (passive candidates) at your competitors and approach them directly. If you rely on applicants, you are only seeing the unhappy or the unemployed.

2. Shift from “Selling Perks” to “Selling Equity”

The Old Way: “We have a great culture like a family and free coffee or parking.”

The 2026 Reality: Candidates are risk-averse. They want to know the commercial viability of your product. Does it have a solid runway? Reimbursement? Demonstratable clinical advantages?

The Strategy: Your Employee Value Proposition (EVP) must be commercial too. Can you show them the pipeline? The reimbursement strategy? The path to equity or bonus? You are selling a business opportunity, not a lifestyle.

3. Shift from “Slow Process” to “The 4-Week Sprint”

The Old Way: A 3-month process with gaps between interviews.

The 2026 Reality: “Time kills all deals.” Top talent is on the market for 10 days, not 10 weeks.

The Strategy: Do not start interviewing until you can commit to a timeline. A structured 4-6 Week Sprint (Briefing>Market Map>Interviews>Offer) keeps momentum high and prevents counteroffers from creeping in.

​

4. Shift from “Gut Feel” to “Data-Led Assessment”

The Old Way: “I liked him, he seems like a good guy ( or gal )”

The 2026 Reality: “Good guys” can still miss targets.

The Strategy: Use rigorous behavioral assessment. Assess for specific competencies: Commercial Acumen, Territory Planning, and Stakeholder Mapping. We don’t ask “What did you do?”; we ask “How did you construct the deal?”

5. Shift from “filling a vacancy” to “building a bench”

The Old Way: Waiting for a resignation letter before calling a recruiter.

The 2026 Reality: By the time you start looking, you have already lost a quarter of revenue.

The Strategy: Proactive Pipelining & Talent Mapping. You should know who the top 3 replacements for your National Sales Manager are right now, even if she or he is happy. This is “Insurance Policy” hiring.

Conclusion: Don’t Use a 2022 Map for 2026 Terrain

The Medtech hiring market has matured. Your hiring strategy must mature with it.

Stop looking for applicants.

Start searching for talent.

Ready to understand your hiring playbook gaps?

> Run the 2-Minute Pre-Hire Diagnostic

The transition from clinical practice or pharmaceuticals into MedTech is not simply a job change. It is a shift in professional operating model.

This piece outlines where that gap most commonly appears — and why it filters capable professionals out of competitive MedTech mandates.

Over the past two years, a consistent pattern has emerged among clinicians and pharmaceutical sales professionals exploring this move.

The motivations are familiar:

• progression ceilings

• income stagnation

• physical burnout

• or the desire to operate at a broader commercial level.

On paper, the move appears logical.

In practice, the failure rate is higher than most anticipate.

The issue is rarely intelligence or clinical credibility.

It is the gap between clinical expertise and commercial ownership.

The transition generally falls into two common pathways — and the friction points are predictable.

Why? Because Clinical Expertise is not Commercial Acumen.

Pathway 1: The Clinical Nurse & Allied Health Pivot

The Advantage: You speak the language. You know the patient journey. You have procedural credibility with surgeons or decision makers because you have “stood next to them in the trenches” within the OR or other departments.

Where It Breaks Down: The Commercial Switch

In a hospital, care is dictated by patient need.

In MedTech, activity is dictated by commercial viability.

The most common friction is not product knowledge.

It is the ability to articulate revenue accountability.

Across recent readiness diagnostic scorecards, fewer than one-third of clinically trained candidates could clearly demonstrate commercial ownership language in early-stage interviews. The gap was rarely technical — it was commercial framing.

The instinct to explain a procedure clearly is different to the instinct to connect that procedure to territory growth, procurement dynamics and quota accountability.

Hiring leaders are assessing the second, not the first.

The pressure of quota, shrinking team structures, and higher financial targets changes the rhythm of work significantly.

The strongest clinical transitions occur when sales is reframed not as persuasion — but as structured clinical advocacy tied to measurable commercial outcomes.

Pathway 2: The Pharma Transition

The Advantage

You understand territory management. You are disciplined in CRM usage. You operate within call cycles and performance metrics.

Where It Breaks Down: Technical Grit & Procedural Immersion

Pharma sales is often process-driven and data-informed around prescribing behaviour.

MedTech — particularly orthopaedics, capital equipment and surgical portfolios — is technical, procedural, procurement-heavy and stakeholder-complex.

The difference is experiential.

In Pharma, engagement may be short-form and repeat-based.

In MedTech, especially surgical, you may be scrubbing in at 6:00am to support a complex case — where technical precision matters more than a polished pitch.

Autonomy increases.

So does accountability.

The scripted GP-rep model does not instantly translate well into an operating theatre environment.

Technical competence, resilience and relationship depth replace presentation folder gloss.

What Hiring Managers Actually Look For

Regardless of your background, MedTech leaders assess three transferable traits:

1. Commercial Drive (The “why”)

Leaving a profession because you are “burnt out” is not enough.

You must be running towards a commercial challenge.

Are you ready for a 20% quota increase while team sizes shrink?

2. Resilience Under Financial Pressure (The “Grit”)

Quota increases. Territory compression. Procurement scrutiny. Irregular hours. The surgical territory is not structured around lifestyle optimisation.

3. Network Intelligence

The “Invisible Market” applies here.

The best roles are not on Seek or job boards. The proof of strongest candidates is their ability to map their networks subject matter experts and identify decision-makers or adjacent supporters to approach or engage with before they even get an interview.

Clinical skill gets you considered.

Commercial ownership gets you hired.

Where Candidates Close the Gap

Don’t just rely on your degree.

To move into MedTech, you must proactively solve the “Experience Gap” before the interview.

• Targeted Research: Pivot to an area related to your current expertise.

  • If you are a Cardiac Nurse, look at Cardiac Rhythm Management.

  • If you sell Orthopaedic medication or come from allied health in a related discipline like physiotherapy, look at Orthopaedic implants.

• Shadowing & Market Mapping: Don’t just “apply” blindly. Reach out to Territory Managers and ask to shadow them. Observing the reality of the role firsthand proves your grit to a hiring manager.

• Upskilling & Education: Use industry-standard training from bodies like the Medical Technology Association of Australia (MTAA) or specialised paid training institutes like the Medical Technology Institute (MTI) to bridge the clinical-commercial knowledge gap.

• Market Intelligence: Listen to legacy resources like the MedTech Mentor podcast to hear the journeys of those who have moved before you, but keep your eye on current industry news via Massdevice and MTPConnect.1

Structured Reflection

Before pursuing a transition, assess:

1. Can you clearly articulate revenue ownership beyond product familiarity?

2. Can you explain margin awareness and procurement dynamics?

3. Are you running toward commercial challenge — or reacting to professional fatigue?

4. Do you understand how retained mandates move before public advertisement?

5. The move into MedTech is achievable.

Before you resign or start applying, benchmark where you actually stand.

The Market Position Scorecard assesses your transferable skills, commercial readiness, and market positioning — giving you a private, structured view of where you sit before you start having conversations.

It’s not a recruiter intake. It’s a self-assessment that gives you clarity first.

Don’t guess. Know.

Find out if you are ready?

When you are operating at, or moving towards, $250k+ roles, you aren’t “job searching”— you are working through a transition.

To land this well, it comes down to how clearly you can align your thinking, your energy, and your commercial value.

For those earlier in the transition, this piece may also be relevant…

1. How People Manage The Process: Search Psychology

The MedTech market is high-touch and often moves slowly.

“Search fatigue” is real—especially for high-performers used to momentum, or those coming back to market after several years.

The people who navigate this well tend to treat it as a strategic process rather than something reactive.

They are clear on what actually matters:

– therapeutic area

– scope

– leadership autonomy

Where that isn’t defined, it’s easy to get pulled into opportunities that don’t quite fit.

They also expect friction.

Clinical timelines shift. Internal approvals stall. Processes take longer than expected.

Those who anticipate that tend to stay composed when things slow down.

And importantly, they maintain their operating rhythm.

Because by the time a real opportunity lands, you’re not just being assessed on experience—you’re being assessed on how you show up.

2. Strategic Alignment: The Interview as a Joint Venture

At this level, interviews aren’t informal conversations—they’re closer to a commercial alignment discussion.

It’s not just about being evaluated. It’s about understanding whether the platform actually supports what you’re trying to build.

That tends to come down to a few things:

– Is there a credible product or pipeline behind the role?

– Does the culture support performance, or recycle people?

– Is there real autonomy, or layers of friction?

How you carry yourself in these conversations matters just as much.

In MedTech, composure under pressure isn’t a soft skill—it’s a core signal. Whether that’s in theatre, with a KOL, or in front of a leadership team.

And the strongest candidates don’t leave the narrative open-ended.

They follow up clearly—linking their experience back to the commercial challenges discussed, and reinforcing why the fit makes sense.

3. How Commercial Impact Is Presented

Regardless of level, one of the clearest differentiators is how commercial impact is articulated.

The strongest profiles are specific.

Not responsibilities—but outcomes.

– revenue growth

– market share shifts

– tenders won

– territories built

If that’s not clear, it’s difficult for a hiring leader to place you commercially.

The same applies to conversations.

People who can clearly connect their experience to real business outcomes tend to stand out quickly.

4: Post-Offer Due Diligence

Getting to offer stage is a position of strength—but it’s also where poor decisions get made if things aren’t properly assessed.

The better operators slow things down here.

They look beyond the headline number and focus on:

– whether the role creates a platform for the next 3–5 years

– how the manager actually operates day to day

– what the broader environment will feel like over time

Because at this level, a misstep isn’t just a bad move—it resets momentum.

This applies just as much to senior individual contributors as it does to leadership roles.

The pattern that shows up

Most missteps at this level don’t come from lack of opportunity.

They come from misalignment that wasn’t picked up early.

The people who navigate this well tend to prioritise clarity over speed.

They’re deliberate about what they’re moving towards—not just what they’re moving away from.

And often, what gets described as a “gut feel” is simply pattern recognition—something not quite lining up beneath the surface.

When that shows up, it’s usually worth paying attention.

Don’t leave your next move to chance.

If you’re feeling friction in the market — or just want to sense-check where you sit — it’s worth taking a step back before pushing forward.

You can position yourself on the 2026 MedTech Talent Map.

It’s one question, and helps build a clearer view of how the market is actually moving.

Position Yourself On the Talent Map 📍

If you want a deeper sense-check, you can also explore the MedTech Market Positioning Scorecard.

Benchmark your value in the invisible market

The “Enduro” Mindset Then & Now

In January 2020, I left a visible legacy medtech recruitment role at an established firm in Sydney to race the Andes-Pacifico in Chile—a multi-day mountain bike enduro challenge.

Racing on “anti-grip” terrain at high altitude taught me a singular truth:

I’d realised the recruitment industry was also running on optimism—racing to send CVs and relying on speed rather than precise navigation.

I didn’t found DukeMed to be another resume-shuffling agency. I founded it to run talent acquisition like an expedition. In the big mountains, you either have the map and the discipline to follow it, or you fail.

I’ve brought that same rigour to the MedTech search market, as “Post-and-Pray” isn’t always a fit-for-purpose option for 2026 and beyond.

We don’t wait for talent to find us; we map the environment, sense-check the reality, and deliver with precision.

The Reality of the Search Led-Intelligence Hiring Pivot

In the early days, I tried to be everything to everyone—offering candidate-led career coaching alongside supporting clients and experimenting with the post-Covid “Rec-Tech” video platforms.

The DukeMed you see today isn’t the one I launched during Covid - I’ve moved beyond the transactional ( and the tech. )

I realised the Medtech industry didn’t need another platform; it needed a search partner with the discipline and conviction to map the landscape before the first interview starts, before the stakes are raised which they are with critical Medtech hires.

The last few months have been a process of stripping back distractions to focus on Standalone Market Modules in addition to search-led hiring.

These are the commercial deep-dives that usually only happen inside a $30k search, now available as unbundled bespoke intelligence reports ( and credited back towards a future search inside your business - you only pay once, not twice ).

Explore the Search Frameworks we deliver at DukeMed :

• 🌐We Map Markets: To ensure you aren’t hiring blind.

• 💰We Audit Market Salaries: To ensure you don’t lose talent to competitors.

• 💗We Check Market Realities: Gathering sentiment so you have the real “pulse check” from the field

And naturally, yes, we also Execute Search in your market or discipline:

Our rigorous, thorough and transparent roadmap for securing the top 15% of the “Invisible Market ” in ~6 weeks.

Explore the Search Intelligence Hub

Our 2026 Commitment: Market-Led Search Intelligence + Best Practice Search Methodology

Whether I am navigating a ridge in the French Alps or mapping a complex commercial territory, the principle is the same:

The best outcomes don’t come from perfection; they come from how fast you adapt, communicate, and reset.

Visibility is the first step to reclaiming control. Which of these hiring ‘friction points’ is currently impacting your team’s commercial momentum?

🔮Your data informs the next briefing. I’ll be sharing the aggregate results of this poll and what they signal for the Q2 MedTech landscape.

In MedTech, there are two distinct hiring ecosystems operating in parallel:

1. The Visible Market:

   Reactive, noisy, and high-volume. It’s where 90% of candidates compete for the 20% of roles that hit LinkedIn.

2. The Invisible Market (Search):

   This is where DukeMed operates. Senior leadership or niche clinical roles that are filled via bespoke Search & Market Mapping—not volume job ads or boards

The Border Chase

Most of you know me from my 17-year tenure in one seat in Sydney, mapping the MedTech landscape. But there was a pivot point. During the height of the lockdowns, I spent 70 days overland, chasing open state borders across the Gulf Savannah and the tropics—from Central QLD to Darwin and back.

I came back from that 70-day chase across the Gulf Savannah with a clean slate. What followed was a period of intense incubation—personally and professionally. My second child was born, and DukeMed was conceived.

I didn’t just want to 'get back to work'; I wanted to build a model that respected the weight of these life-changing transitions—for you, and for the clients I partner with.

Navigating the tropics when the maps are changing in real-time teaches you one thing:

The best outcomes don’t come from perfection; they come from how fast you adapt and communicate.

I’ve applied that same "MTB Enduro" mindset to the relaunch of the DukeMed website and engagement framework.

I’ve spent the time since mid-2023—and specifically the recent summer reset—refining a model that respects your time as much as it respects the client’s bottom line.

The “Hard Cut”: Why I’ve Changed How I Work

In the past, recruitment was often about “dangling carrots”—gossip and “maybes.”

As a solo operator, I’ve made a Hard Cut. I have moved from “chats” to Search Intelligence.

• Context Over CVs: I want to understand your trajectory before we even look at a job spec.

• Truth as a Standard: If a search mandate isn’t a 100% “Grip” match for you, I’ll tell you early. No loops. No “limbo.”

• Data Over Gossip: I provide diagnostics and market insights to help you position yourself, so you don’t have to “chase” roles.

The Framework of Engagement

I am a ‘one-man band” by design. This allows me to go deep—not wide.

My engagement follows a structured path:

Self-Guided: Diagnostics to help you sense-check your position privately.

Contextual: Short, focused conversations to surface reality, not to “intake” you into a database.

Search-Led: Visibility only within defined, committed mandates where alignment is verified.

Audit Your Market Positioning

• Move beyond a simple poll and understand how your specific trajectory aligns with the 2026 “Invisible Market,” I invite you to audit your position readiness via the MedTech Market Positioning Scorecard.

  If you want to benchmark how your profile is currently positioned within retained mandates and emerging demand pockets, the MedTech Market Positioning Scorecard provides a structured, independent view of your market alignment.

  Begin

Share Inside MedTech Hiring

Share

Over recent weeks, we’ve wrapped up the Ortho Moves Index 💬, one of the most comprehensive looks yet at what’s driving career movement across Australia’s orthopaedic sales market.

The insights from that project, plus ongoing search-led hiring conversations, are already showing clear signals 🛜 about what’s ahead.

It’s already sparked some interesting conversations with hiring leaders across Australia.

If you’d like to see the full Ortho Moves Index employer deck — with anonymised insights from across ANZ — just click the “Message Richard” button below and I’ll send you a copy directly.

We’re now heading into the busiest part of the year with only 46 working days left in 2025.⚡️📆 — when new budgets, restructures, and quiet career moves collide. Over the coming weeks, you’ll see fresh Hiring Signals episodes 🎧 and short audio posts tracking salary shifts, sentiment changes, and the noise behind the numbers.

I’ll also be sharing a few audio versions of earlier posts and articles ⏪—think of them as a back catalogue of the topics that started it all, in bite-sized, easy-to-listen-to, and follow-along chunks.

PS (Later this year, I’ll also launch a separate channel focused on candidate perspectives and career direction — stay tuned for that.)

Share Inside MedTech Hiring

Meanwhile, candidates are often sitting quietly, waiting—uncertain whether to move, whether they’re still relevant, or whether anything better is really out there.

---

Why I started this newsletter:

I’m Richard Duke, and I run DukeMed Pty Ltd—a search-led recruitment firm focused on solving Medtech commercial and leadership “hiring headaches” across Australia (and the APAC region). Each week, I speak with hiring leaders, talented candidates, and HR execs about what’s actually happening on the ground & how to improve.

Inside MedTech Hiring exists to share those patterns:

• Salary pressure that’s not visible in published bands

• Shifts in candidate sentiment—what they’re valuing, fearing, or ignoring

• Hiring blind spots that cost companies standout talent

• And the quiet moves happening behind the scenes

What to expect:

• 📌 Short signal-led posts or audio soundbites (1–2x per week tops)

• 📈 Market movement summaries, drawn from live search work or market index surveys & quiz

• 🎯 Practical, honest takeaways—no fluff, no preaching

Free content will land regularly.

Paid insight reports and strategy drops are coming soon—for those who want to stay ahead of the market before it shifts again.

Thanks for being here.

— Richard

Subscribe now